WTF with Race Oncology: Changing the chemo game

What is traditional chemotherapy? How is Race Oncology trying to change it? What are the alternative cancer treatments?

Race Oncology (ASX:RAC) chief executive Dr Daniel Tillett joins the Stockhead TV studio to investigate these questions and more.

“Cancer is a really difficult disease to treat, it’s actually not one disease it’s millions of diseases and each cancer has to be treated uniquely,” Tillett said.

“The problem with that is, it’s really hard to match the treatment with the patients that will work best for them.”

Stockhead’s Sarah Hughan sits down Dr. Tillett to learn more about cancer, cancer treatments and more.